The Use of a Platform Wound Device for Reducing Infection

Summary

This study will evaluate the safety and efficacy of a novel Platform Wound Device (PWD) in its delivery of a local antibiotic, 0.1% Gentamycin cream, to prevent or treat infection in torso and extremity wounds. The hypothesis is that the PWD will be a safe and effective method to provide topical antibiotics to a torso or extremity wound, non-inferior to the current standard of care. This treatment will reduce or rapidly eradicate infection.

Timeline

Start

2021-02-08

Primary completion

2021-11-19

Completion

2022-05-25

Drugs

Indications